Meeting Banner
Abstract #2762

MR Determind Metabolites May Serve as Prognostic Factors in Breast Cancer

Tone Frost Bathen1, Beathe Sitter1, Guro F. Giskedegrd1, Lutgarde Buydens2, Geert Postma2, Hans Fjsne3, Steinar Lundgren1,4, Ingrid S. Gribbestad1

1Dept. of Circulation and Medical Imaging, NTNU, Trondheim, Norway; 2Dept. of Analytical Chemistry, Radboud University Nijmegen, Nijmegen, Netherlands; 3Dept. of Surgery, St. Olavs University Hospital, Trondheim, Norway; 4Dept. of Oncology, St.Olavs University Hospital, Trondheim, Norway

The purpose of the current study was to define new prognostic factors for breast cancer based on HR MAS MRS. Proton MR spin echo spectra were acquired from excised breast cancer tissue. 5-years follow-up data were available for all included patients. The spectra were analysed with PCA. Using ROC and Kaplan-Meyer survival analysis of score values, two groups with significant different cumulative survival were defined. Higher levels of glycerophosphocholine, betaine and creatine, and lower levels of lactate and glycine were associated to good prognosis. A combination of MR determined metabolites may serve as an additional prognostic factor in breast cancer.